CHRISTINE HELOU: Open Payments
NPI 1528318334 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,170 in 17 payments from 14 companies in 2025. Trend: 2023 $1,636 · 2024 $1,447 · 2025 $3,170
Consulting: $2,825Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $2,525 |
| Chiesi USA, Inc. | 1 | $300 |
| ABBVIE INC. | 2 | $70 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Celgene Corporation | 1 | $28 |
| PharmaEssentia USA Corporation | 1 | $28 |
| Incyte Corporation | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
Products named: RYBREVANT, FERRIPROX, EPKINLY, REBLOZYL, BESREMI, Jakafi, LYNOZYFIC, TAVALISSE.
Industry payments across VA — which companies pay providers there.
